AAAAAA

   
Results: 1-13 |
Results: 13
FLUORIDE TREATMENT OF OSTEOPOROSIS - CURR ENT STATUS
Authors: HUFNER M SIGGELKOW H
Citation: M. Hufner et H. Siggelkow, FLUORIDE TREATMENT OF OSTEOPOROSIS - CURR ENT STATUS, Deutsche Medizinische Wochenschrift, 123(22), 1998, pp. 713-717
THE USE OF CONFLUENCE STAGES DOES NOT DECREASE THE OVERALL VARIABILITY IN PRIMARY HUMAN OSTEOBLASTS BUT CAN GIVE ADDITIONAL INFORMATION ON DIFFERENTIATION IN-VITRO
Authors: SIGGELKOW H BENZLER K ATKINSON MJ HUFNER M
Citation: H. Siggelkow et al., THE USE OF CONFLUENCE STAGES DOES NOT DECREASE THE OVERALL VARIABILITY IN PRIMARY HUMAN OSTEOBLASTS BUT CAN GIVE ADDITIONAL INFORMATION ON DIFFERENTIATION IN-VITRO, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 106(3), 1998, pp. 217-225
IN-VITRO DIFFERENTIATION POTENTIAL OF A NEW HUMAN OSTEOSARCOMA CELL-LINE (HOS-58)
Authors: SIGGELKOW H NIEDHART C KURRE W IHBE A SCHULZ A ATKINSON MJ HUFNER M
Citation: H. Siggelkow et al., IN-VITRO DIFFERENTIATION POTENTIAL OF A NEW HUMAN OSTEOSARCOMA CELL-LINE (HOS-58), Differentiation, 63(2), 1998, pp. 81-91
THE HUMAN ANALOG OF MURINE CYSTEIN RICH PROTEIN-16 IS A 1-ALPHA,25-DIHYDROXYVITAMIN D-3 RESPONSIVE IMMEDIATE-EARLY GENE IN HUMAN FETAL OSTEOBLASTS - REGULATION BY CYTOKINES, GROWTH-FACTORS, AND SERUM
Authors: SCHUTZE N LECHNER A GROLL C SIGGELKOW H HUFNER M KOHRLE J JAKOB F
Citation: N. Schutze et al., THE HUMAN ANALOG OF MURINE CYSTEIN RICH PROTEIN-16 IS A 1-ALPHA,25-DIHYDROXYVITAMIN D-3 RESPONSIVE IMMEDIATE-EARLY GENE IN HUMAN FETAL OSTEOBLASTS - REGULATION BY CYTOKINES, GROWTH-FACTORS, AND SERUM, Endocrinology, 139(4), 1998, pp. 1761-1770
ANALYSIS OF HUMAN PRIMARY BONE-CELLS BY FLUORESCENCE-ACTIVATED CELL SCANNING - METHODOLOGICAL PROBLEMS AND PRELIMINARY-RESULTS
Authors: SIGGELKOW H HILMES D REBENSTORFF K KURRE W ENGEL I HUFNER M
Citation: H. Siggelkow et al., ANALYSIS OF HUMAN PRIMARY BONE-CELLS BY FLUORESCENCE-ACTIVATED CELL SCANNING - METHODOLOGICAL PROBLEMS AND PRELIMINARY-RESULTS, Clinica chimica acta, 272(2), 1998, pp. 111-125
NEONATAL GRAVES-DISEASE IN TWINS BORN OF A MOTHER WITH SEVERE T-3 HYPERTHYROIDISM
Authors: ROTH C SIGGELKOW H GRUTERS A HUFNER M LAKOMEK M
Citation: C. Roth et al., NEONATAL GRAVES-DISEASE IN TWINS BORN OF A MOTHER WITH SEVERE T-3 HYPERTHYROIDISM, Deutsche Medizinische Wochenschrift, 122(18), 1997, pp. 572-577
LOCAL ESTRADIOL METABOLISM IN OSTEOBLAST-LIKE AND OSTEOCLAST-LIKE CELLS
Authors: JAKOB F SIGGELKOW H HOMANN D KOHRLE J ADAMSKI J SCHUTZE N
Citation: F. Jakob et al., LOCAL ESTRADIOL METABOLISM IN OSTEOBLAST-LIKE AND OSTEOCLAST-LIKE CELLS, Journal of steroid biochemistry and molecular biology, 61(3-6), 1997, pp. 167-174
ALKALINE-PHOSPHATASE POSITIVE HUMAN OSTEOBLASTS IN CULTURE SHOW A HIGH VARIATION IN ALKALINE-PHOSPHATASE PRODUCTION-RATE BETWEEN DIFFERENT NORMAL DONORS
Authors: SIGGELKOW H HILMES D REBENSTORFF K KURRE W HUFNER M
Citation: H. Siggelkow et al., ALKALINE-PHOSPHATASE POSITIVE HUMAN OSTEOBLASTS IN CULTURE SHOW A HIGH VARIATION IN ALKALINE-PHOSPHATASE PRODUCTION-RATE BETWEEN DIFFERENT NORMAL DONORS, Journal of bone and mineral research, 11, 1996, pp. 370-370
PROPHYLACTIC APPLICATION OF THYROSTATIC DRUGS DURING EXCESSIVE IODINEEXPOSURE IN EUTHYROID PATIENTS WITH THYROID AUTONOMY - A RANDOMIZED STUDY
Authors: NOLTE W MULLER R SIGGELKOW H EMRICH D HUFNER M
Citation: W. Nolte et al., PROPHYLACTIC APPLICATION OF THYROSTATIC DRUGS DURING EXCESSIVE IODINEEXPOSURE IN EUTHYROID PATIENTS WITH THYROID AUTONOMY - A RANDOMIZED STUDY, European journal of endocrinology, 134(3), 1996, pp. 337-341
CAN PERCUTANEOUS ETHANOL INJECTION REPLACE RADIOIODINE THERAPY IN PLUMMERS-DISEASE
Authors: SANDROCK D GRATZ S SIGGELKOW H MELLER J BECKER W MUNZ DL
Citation: D. Sandrock et al., CAN PERCUTANEOUS ETHANOL INJECTION REPLACE RADIOIODINE THERAPY IN PLUMMERS-DISEASE, The Journal of nuclear medicine, 37(5), 1996, pp. 1142-1142
THE IRON-BINDING PROTEIN FERRITIN IS EXPRESSED IN CELLS OF THE OSTEOBLASTIC LINEAGE IN-VITRO AND IN-VIVO
Authors: SPANNER M WEBER K LANSKE B IHBE A SIGGELKOW H SCHUTZE H ATKINSON MJ
Citation: M. Spanner et al., THE IRON-BINDING PROTEIN FERRITIN IS EXPRESSED IN CELLS OF THE OSTEOBLASTIC LINEAGE IN-VITRO AND IN-VIVO, Bone, 17(2), 1995, pp. 161-165
OSTEOPOROSIS PROPHYLAXIS WHY - WHO - HOW
Authors: SIGGELKOW H HUFNER M
Citation: H. Siggelkow et M. Hufner, OSTEOPOROSIS PROPHYLAXIS WHY - WHO - HOW, Medizinische Klinik, 90(11), 1995, pp. 639-644
PROLIFERATION AND DIFFERENTIATION OF HUMAN OSTEOBLAST-LIKE CELLS IN CULTURE - AN IN-VITRO MODEL OF OSTEOBLAST DEVELOPMENT
Authors: SIGGELKOW H BEHRENS K IPSEN C ATKINSON MJ HUFNER M
Citation: H. Siggelkow et al., PROLIFERATION AND DIFFERENTIATION OF HUMAN OSTEOBLAST-LIKE CELLS IN CULTURE - AN IN-VITRO MODEL OF OSTEOBLAST DEVELOPMENT, Journal of bone and mineral research, 8, 1993, pp. 190000300-190000300
Risultati: 1-13 |